Contrast
Contact
Share
Donate
MyChart
Critical Care Medicine, Pulmonary Disease Medicine, Internal Medicine
Asbestos Disease, Autoimmune Disease, Bronchoscopy, Connective Tissue Disease, Critical Care, Dermatomyositis, Eosinophilic pneumonias, Hypersensitivity pneumonitis, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Interstitial Pneumonia, Lung Disease, Lupus, Lymphocytic Interstitial Pneumonia, Pediatric Airways, Pneumonia, Polymyositis, Pulmonary alveolar proteinosis, Pulmonary Disease, Pulmonary Fibrosis, Pulmonary Function Testing, Recurrent Infections, Respiratory Failure, Rheumatoid Arthritis, Sarcoidosis, Scleroderma, Silicosis, Wegener's Granulomatosis
Female
Yale Medicine
English
Read BiographyPrinceton University;University of Pennsylvania School of Medicine
University of Pennsylvania Health System
University of Pennsylvania Health System
20 York Street
New Haven, CT 06510
Main (203) 785-4198
Fax (203) 737-5453
6 Devine Street
North Haven, CT 06473
Main (203) 495-2410
Fax (203) 239-8290
789 Howard Ave
Fitkin Memorial Pavilion - 2nd Flr
New Haven, CT 06519
Main (203) 785-4787
Fax (203) 737-5453
Insurance coverage regularly changes, please contact the doctor’s office directly to verify that your specific insurance plan is accepted.
Phone
(203) 785-4198Danielle Antin-Ozerkis, MD, specializes in the evaluation and management of advanced lung disease. She is the medical director of the Yale Medicine Interstitial Lung Disease Program and cares for patients with all forms of the disease.
“We look for any signs of connective tissue disease and for possible exposures in the workplace and home (such as birds and mold), all of which can lead to interstitial lung disease,” explains Dr. Antin-Ozerkis. “We have a dedicated multidisciplinary group that meets weekly to discuss patient cases and research. Everything we do keeps the focus on the patient. It is so important to get the diagnosis right, as the correct treatment hinges on this. Sometimes the therapy involves new antifibrotic drugs. Other patients may require immunosuppressive therapy. For some, clinical trials are an option. We also focus on quality of life, exercise, oxygen, nutrition and emotional support.”
An associate professor of medicine (pulmonary) at Yale School of Medicine, Dr. Antin-Ozerkis says she enjoys the complexities of pulmonary medicine and the personalized approach involved in treating it. “I love talking with people and trying to understand the reasons they became ill,” she says. “Each time I can sit with a patient and talk with them about their disease in a way that they haven't heard before makes my work feel worthwhile.”
Is this your profile? Request an Edit »